Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
about
The role of brain-derived neurotrophic factor in the pathophysiology of adolescent suicidal behaviorOxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant ApproachesIs there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderMood disorders: A potential link between ghrelin and leptin on human body?R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effectsCaptodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonismRole of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in miceBiomarkers in pediatric depressionPlasma BDNF levels vary in relation to body weight in femalesDifferential Behavioral and Neurobiological Effects of Chronic Corticosterone Treatment in Adolescent and Adult RatsAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with KetamineDepression and Associated Factors in Patients with Implantable Cardioverter-Defibrillators.Decrease in brain-derived neurotrophic factor at plasma level but not in serum concentrations in suicide behavior: A systematic review and meta-analysis.A narrative literature review of depression following traumatic brain injury: prevalence, impact, and management challengesDepression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failureSocial isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stressSerum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalanceDNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients.Overview of the genetics of major depressive disorderGlutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.Decreased serum levels of mature brain-derived neurotrophic factor (BDNF), but not its precursor proBDNF, in patients with major depressive disorder.State-related alterations of gene expression in bipolar disorder: a systematic review.Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.Pathway analysis using information from allele-specific gene methylation in genome-wide association studies for bipolar disorder.Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder?Reduced serum brain-derived neurotrophic factor in patients with first onset vitiligo.Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment.Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine?Antibody profiling of bipolar disorder using Escherichia coli proteome microarraysSerum BDNF levels before treatment predict SSRI response in depressionDecreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndromePostsynaptic TRPC1 function contributes to BDNF-induced synaptic potentiation at the developing neuromuscular junctionAn Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia.Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF.
P2860
Q22306030-45A77184-6644-40A8-A09E-4DC9DD74D270Q26738789-E1F2CB20-43AB-4F1D-A7FD-F3C3D61ABA6FQ26747511-D48DC4EF-F4F6-416A-9C68-3C192D5274EBQ26862798-A579C350-23DD-4FC9-A78E-BD104A956884Q28266846-73053077-EA1C-4C3F-8FC1-893D7D7D2F7AQ28294674-495CBCA8-3E40-4A7A-8639-8450F73EAFB9Q28385414-EFFBA09E-6547-4BF9-BBF0-8D93EDE5B6B7Q28389366-FEEEF175-B5D1-4582-93AE-26A6C983BC9EQ28727632-62D19A8A-BB0A-4850-A20C-9028B4E3C391Q30363153-FFB8D6C5-72D3-46F9-A785-0E786136AA24Q30372214-58C9DF21-8933-4171-9CE7-CDF12DE13257Q30375488-3BC8E7D0-0F13-41B7-9574-7BD90B7FC0F0Q33614178-210767CB-0B0E-409F-A85C-13B27F37F8C7Q33656655-53165331-9752-44A8-8DAA-6D081B10D81AQ33810104-AEF71036-C328-4122-B916-6131D7BED6D6Q33813083-7FD115D1-CB5B-4956-B8E3-FBD37AF0C2CCQ33890188-69F6B8D8-FBE7-4323-99BF-7C6D4680CA52Q33940576-4451A3FA-E0A4-4549-8C8B-45E1BD123E0BQ33986157-CCD46355-0BD6-4BA4-AAC9-89D5A8C76945Q34008826-C9C7AA6B-3341-4C72-8AE3-BEF92AF6A3DCQ34017635-AA540B94-FDD1-45F8-A32A-17FAFD0C8D13Q34026112-B6968306-6358-4AA1-AD79-E78B402A4EB2Q34138509-9D45C661-26F5-4FF4-8C58-537FDABEB62AQ34330678-73715B2C-E18F-4A19-BCD0-1C95BC9A9BFCQ34374580-68264AEE-FE88-43D0-8C2E-1DAFA2C63039Q34436227-AA8E19EB-B7D7-410D-92EE-DCB3F30B9DCCQ34460057-66C206C6-ADE9-4047-A4EC-4551342A5909Q34492381-2DD5FF4F-2717-4F9E-A4CB-BC3D548177E3Q34499572-C03CDEA6-662C-48FA-866B-A0F90C6A348DQ34551182-3AB4C2BF-1629-4FA9-8B27-95B71CEE6230Q34610802-BC8AFFA0-247D-404B-999C-BF20FECF6D10Q34731431-AB9FCA9D-1175-461C-9F5D-77235B2F2BF6Q35094654-EFF7572A-AE2C-4046-ACF2-E2587D8C6DCDQ35117810-4788B67A-C3A9-4115-BB2C-521384A93482Q35148349-71203FC6-2A27-4858-A670-EF3436651267Q35173385-06E34B9F-F042-4EF3-9C9B-499742F7C76BQ35284133-BA22C3F1-A195-404B-9743-75BE16EC945CQ35541445-7E068001-0551-4547-87A8-DCB0C4C5EF4BQ35579197-38D89EFA-9D59-4F6F-B348-2E373E42846CQ35618999-884DA10D-527B-4BF8-A532-04D7D34F21C8
P2860
Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Brain-derived neurotrophic fac ...... verview and future directions.
@ast
Brain-derived neurotrophic fac ...... verview and future directions.
@en
Brain-derived neurotrophic fac ...... verview and future directions.
@nl
type
label
Brain-derived neurotrophic fac ...... verview and future directions.
@ast
Brain-derived neurotrophic fac ...... verview and future directions.
@en
Brain-derived neurotrophic fac ...... verview and future directions.
@nl
prefLabel
Brain-derived neurotrophic fac ...... verview and future directions.
@ast
Brain-derived neurotrophic fac ...... verview and future directions.
@en
Brain-derived neurotrophic fac ...... verview and future directions.
@nl
P2860
P1476
Brain-derived neurotrophic fac ...... overview and future directions
@en
P2093
Kenji Hashimoto
P2860
P304
P356
10.1111/J.1440-1819.2010.02113.X
P50
P577
2010-08-01T00:00:00Z